Kew Gardens, New York Clinical Trials

A listing of Kew Gardens, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 544 clinical trials
The Young Heart Study

The purpose of our project is to better understand the characteristics of the young patients with coronary artery disease presenting for cardiac catheterization at our institution and to put forth a program to optimize their risk factors with a focus on gender differences. We will assess traditional and non-traditional risk …

arterial disease
heart study
depression
atherosclerosis
anxiety
Lenox Hill Hospital
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

formalin-fixed paraffin-embedded
immunosuppressive
adenosquamous cell carcinoma of the cervix
metastatic cervical cancer
prednisone
Northwell Health LLC
 (7.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +19 other locations
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

This is a multicenter, open-label Phase 1 study of orally administered CB-5339 in participants with R/R AML or participants with R/R intermediate- to high-risk MDS.

acute myeloid leukemia
remission
leukemia
bone marrow procedure
cancer
Memorial Sloan Kettering Cancer Center
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

This study will find out whether people with CLL or SLL who have received treatment with venetoclax, either alone or in combination with another drug, and who are found to be MRD-negative, can stop treatment with venetoclax and remain off-treatment for 12 months or more. The researchers will also see …

monoclonal protein
formalin-fixed paraffin-embedded
leukemia
minimal residual disease
bone marrow biopsy
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

prostatic neoplasms, castration-resistant
castration-resistant prostate cancer
measurable disease
cancer
taxane
New York University, Langone Health
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

diarrhea
sore throat
serologic test
systemic therapy
cns neoplasms
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Acne study trial

hello Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!

New Site with only Phone
 (9.3 away) Contact site
  • 6 views
  • 04 Aug, 2023
  • 1 location
ctgov trial 2

    dddd

Test Site
 (8.3 away) Contact site
  • 0 views
  • 20 Aug, 2020
  • 1 location
Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Primary Objectives: Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. Phase 2: To evaluate the efficacy of isatuximab in desensitization of patients awaiting kidney transplantation. Secondary Objectives: Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. To characterize the pharmacokinetic …

diphenhydramine
chronic kidney disease
isatuximab
nephropathy
sar650984
Investigational Site Number 8400002
 (8.3 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +2 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

autologous hematopoietic stem cell transplant
monoclonal protein
proteasome inhibitor
cell transplantation
monoclonal antibodies
Investigational Site Number 8400001
 (8.4 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations